Dynamic angiogenic switch as predictor of response to chemotherapy+ bevacizumab in patients with metastatic colorectal cancer

Authors :: Sofia Perea
Maria Dolores Martin
Lisardo Ugidos
Cesar Munoz
Yolanda Quijano
Rodrigo A. Toledo
Manuel Muñoz
Elena Garralda
Estela Vega
Gema Sanchez
Rafael Alvarez-Gallego
Manuel Hidalgo
Gregory R. Pond
Emilio Vicente
Antonio Cubillo
Jesus Rodriguez-Pascual
Source :: Journal of Clinical Oncology. 34:e15126-e15126
Publication Year :: 2016
Publisher :: American Society of Clinical Oncology (ASCO), 2016.
Abstract: e15126Background: There is a need to develop biomarkers to predict the outcome of patients with metastatic colorectal cancer (CRC) treated with chemotherapy (Ch) plus Bevacizumab (B). It has been r...

Full Text Access

Tools